Literature DB >> 21137315

[Evaluation of recombinant 29,000 extra membranous protein for the immunodiagnosis of schistosomiasis japonica].

Ping Wang1, Cui-ping Ren, Tian-ping Wang, Ji-jia Shen.   

Abstract

OBJECTIVE: To evaluate the recombinant membranous protein 29000 (rSj29) of Schistosoma japonicum in the immunodiagnosis of schistosomiasis by indirect ELISA.
METHODS: 394 serum samples collected from two low-endemic villages in Anhui Province were tested by rSj29-ELISA and AWA-ELISA using adult worm antigen (AWA) of S. japonicum. Meanwhile all subjects were each tested by 9 examinations with 3 fecal samples by modified Kato-Katz method, and by indirect hemagglutination assay (IHA).
RESULTS: It was found that the positive detection rates of stool examination, IHA, rSj29-ELISA and AWA-ELISA were 4.8% (19/394), 62.2% (245/394), 68.3% (269/394), and 89.9% (354/394), respectively. There was no statistical difference between rSj29-ELISA and IHA (chi2 = 3.2, P > 0.05) with the coincidence of 80.7% (318/394). The coincidence of IHA, rSj29-ELISA and AWA-ELISA with stool examination was 42.6% (168/394), 36.0% (142/394), and 15.0% (59/394), respectively.
CONCLUSION: The indirect ELISA with rSj29 antigen shows similar effect as IHA for the diagnosis of schistosomiasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21137315

Source DB:  PubMed          Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi        ISSN: 1000-7423


  2 in total

1.  Diagnostic test accuracy for detecting Schistosoma japonicum and S. mekongi in humans: A systematic review and meta-analysis.

Authors:  Md Obaidur Rahman; Miho Sassa; Natasha Parvin; Md Rashedul Islam; Aya Yajima; Erika Ota
Journal:  PLoS Negl Trop Dis       Date:  2021-03-17

2.  The Efficiency of Commercial Immunodiagnostic Assays for the Field Detection of Schistosoma japonicum Human Infections: A Meta-Analysis.

Authors:  Zhongqiu Mei; Shan Lv; Liguang Tian; Wei Wang; Tiewu Jia
Journal:  Pathogens       Date:  2022-07-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.